{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:25:57Z","timestamp":1777699557499,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.cyto.2015.05.025","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T19:57:19Z","timestamp":1436039839000},"page":"144-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Endothelin 1 and transforming growth factor-\u03b21 correlate with liver function and portal pressure in cirrhotic patients"],"prefix":"10.1016","volume":"76","author":[{"given":"Urszula","family":"Wereszczynka-Siemiatkowska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Swidnicka-Siergiejko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Siemiatkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofia","family":"Bondyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Wasielica-Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Janica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.05.025_b0005","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1053\/j.gastro.2008.03.007","article-title":"Portal hypertension and its complications","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2015.05.025_b0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Practice guidelines committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0025","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.24129","article-title":"Noninvasive assessment of portal hypertension in patients with cirrhosis","volume":"53","author":"Thabut","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2010.03.021","article-title":"Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension","volume":"53","author":"Bosch","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jhep.2012.03.007","article-title":"Functional aspects on the pathophysiology of portal hypertension in cirrhosis","volume":"57","author":"Garc\u00eda-Pag\u00e1n","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cld.2008.07.004","article-title":"Stellate cell contraction: role, regulation, and potential therapeutic target","volume":"12","author":"Soon","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cyto.2015.05.025_b0045","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1006\/cyto.1999.0660","article-title":"Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis","volume":"12","author":"Flisiak","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2015.05.025_b0050","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/gut.2005.088633","article-title":"Role of endothelin in systemic and portal resistance in cirrhosis","volume":"55","author":"Angus","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0055","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/hep.23917","article-title":"The role of intestinal endotoxin in liver injury: a long and evolving history","volume":"52","author":"Nolan","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4137\/BMI.S10009","article-title":"Molecular serum markers of liver fibrosis","volume":"7","author":"Liu","year":"2012","journal-title":"Biomark Insights"},{"key":"10.1016\/j.cyto.2015.05.025_b0065","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.159.8.3961","article-title":"IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice","volume":"159","author":"Tsutsui","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2015.05.025_b0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.510280308","article-title":"Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats","volume":"8","author":"Sogni","year":"1998","journal-title":"Hepatology"},{"issue":"1042\u201354","key":"10.1016\/j.cyto.2015.05.025_b0075","first-page":"e4","article-title":"Transforming growth factor-\u03b2 signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1","volume":"144","author":"Yang","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2015.05.025_b0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-2007-1007130","article-title":"Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension","volume":"19","author":"Garc\u00eda-Pag\u00e1n","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cyto.2015.05.025_b0085","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0095","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/gut.2005.077453","article-title":"Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial","volume":"55","author":"Tripathi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/gut.52.3.410","article-title":"Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide","volume":"52","author":"Helmy","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s005990070002","article-title":"Plasma endothelin-1 levels in liver cirrhosis","volume":"30","author":"Bruno","year":"2000","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.cyto.2015.05.025_b0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gut.52.10.1505","article-title":"Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation","volume":"52","author":"Vaughan","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00024382-200201000-00007","article-title":"Endothelin receptor remodeling induces the portal venous hyper-response to endothelin-1 following endotoxin pretreatment","volume":"17","author":"Yokoyama","year":"2002","journal-title":"Shock"},{"key":"10.1016\/j.cyto.2015.05.025_b0120","doi-asserted-by":"crossref","first-page":"L361","DOI":"10.1152\/ajplung.00464.2010","article-title":"TGF-\u03b22 reduces nitric oxide synthase mRNA through a ROCK-dependent pathway in airway epithelial cells","volume":"301","author":"Jiang","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cyto.2015.05.025_b0125","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.23156","article-title":"Nitric oxide suppresses transforming growth factor-beta1-induced epithelial-to-mesenchymal transition and apoptosis in mouse hepatocytes","volume":"50","author":"Pan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jhep.2010.07.026","article-title":"TGF-\u03b21 mediated activation of Rho kinase induces TGF-\u03b22 and endothelin-1 expression in human hepatic stellate cells","volume":"54","author":"Shimada","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.22934","article-title":"The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis","volume":"50","author":"Weng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0140","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MEG.0b013e328343700a","article-title":"Portal levels of latent transforming growth factor-\u03b2 are related to liver function in patients with liver cirrhosis","volume":"23","author":"Wanninger","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/IAI.74.2.1215-1221.2006","article-title":"Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans","volume":"74","author":"Alves Oliveira","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.cyto.2015.05.025_b0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2015.05.025_b0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.05.025_b0160","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20030917","article-title":"Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis","volume":"198","author":"Kitani","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2015.05.025_b0165","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/gutjnl-2012-302826","article-title":"Beyond scoring: a modern interpretation of disease progression in chronic liver disease","volume":"62","author":"Rosselli","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2015.05.025_b0170","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastroesophageal varices and variceal bleeding","volume":"5","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2015.05.025_b0175","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatiz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2015.05.025_b0180","first-page":"266","article-title":"Natural history and prognostic factors of survival in cirrhosis: a systematic review of 118 studies","volume":"38","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0185","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","article-title":"Non-selective beta-blocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis","volume":"58","author":"Reiberger","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.05.025_b0190","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1080\/00365520600780403","article-title":"Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes","volume":"41","author":"Bruha","year":"2006","journal-title":"Scand J Gastroenterol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:49:43Z","timestamp":1691801383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1043466615002112"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.05.025","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin 1 and transforming growth factor-\u03b21 correlate with liver function and portal pressure in cirrhotic patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}